Abstract
Maltodextrin, a polysaccharide derived from enzymatic hydrolysis of starch, is widely used in processed foods due to its multifunctional roles as a thickener, filler, and texturizer. Despite its seemingly innocuous classification as a complex carbohydrate, maltodextrin exhibits a high glycemic index (GI) comparable to or exceeding that of glucose, leading to rapid blood sugar spikes and potential metabolic disruptions. This characteristic, coupled with its ubiquitous use across a spectrum of consumables—from sports drinks and infant formulas to meal replacement bars—raises significant public health concerns.
This paper critically examines maltodextrin’s biochemical structure, functional applications, and regulatory classification, while investigating its metabolic effects, interaction with gut microbiota, and association with chronic conditions such as insulin resistance and inflammatory bowel disease (IBD). The study synthesizes current literature and market data to highlight how maltodextrin often escapes classification as a “sugar” on nutrition labels, allowing it to remain undetected by consumers aiming to reduce sugar intake.
Empirical evidence and survey results further reveal a disconnect between scientific knowledge and consumer awareness, suggesting an urgent need for improved labeling standards and public education. By integrating chemical analysis, literature review, regulatory assessment, and consumer insights, this research underscores the necessity of reevaluating maltodextrin’s role in processed foods. It also calls for the development of transparent food policies and the use of alternative low-GI polysaccharides that align with metabolic health goals.
Keywords
- Maltodextrin
- Hidden Sugars
- Processed Foods
- Glycemic Index
- Food Labeling
- Gut Microbiota
- Metabolic Health
- Food Additives